Cargando…

Mesenchymal stem cells - a promising therapy for Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome (ARDS) constitutes a spectrum of severe acute respiratory failure in response to a variety of inciting stimuli that is the leading cause of death and disability in the critically ill. Despite decades of research, there are no therapies for ARDS, and management rem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayes, Mairead, Curley, Gerard, Laffey, John G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculty of 1000 Ltd 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251316/ https://www.ncbi.nlm.nih.gov/pubmed/22238514 http://dx.doi.org/10.3410/M4-2

Ejemplares similares

Clinical review: Stem cell therapies for acute lung injury/acute respiratory distress syndrome - hope or hype?
por: Hayes, Mairead, et al.
Publicado: (2012)

Cell therapy demonstrates promise for acute respiratory distress syndrome - but which cell is best?
por: Curley, Gerard F, et al.
Publicado: (2013)

Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome
por: Horie, Shahd, et al.
Publicado: (2016)

Lung stem cells - from an evolving understanding to a paradigm shift?
por: Hayes, Mairéad, et al.
Publicado: (2011)

Can 'permissive' hypercapnia modulate the severity of sepsis-induced ALI/ARDS?
por: Curley, Gerard, et al.
Publicado: (2011)

Mesenchymal stromal cells are more effective than the MSC secretome in diminishing injury and enhancing recovery following ventilator-induced lung injury
por: Hayes, Mairead, et al.
Publicado: (2015)

Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome
por: Han, Jibin, et al.
Publicado: (2019)

Advances of mesenchymal stem cells and their derived extracellular vesicles as a promising therapy for acute respiratory distress syndrome: from bench to clinic
por: Zhuang, Xiaoli, et al.
Publicado: (2023)

Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics
por: Qin, Hua, et al.
Publicado: (2020)

Strategies to Enhance Mesenchymal Stem Cell-Based Therapies for Acute Respiratory Distress Syndrome
por: Han, Jibin, et al.
Publicado: (2019)

Use of a novel “Split” ventilation system in bench and porcine modeling of acute respiratory distress syndrome
por: Geoghegan, Pierce, et al.
Publicado: (2022)

Machine Learning Classifier Models: The Future for Acute Respiratory Distress Syndrome Phenotyping?
por: McNicholas, Bairbre, et al.
Publicado: (2020)

Compliance Phenotypes in Early Acute Respiratory Distress Syndrome before the COVID-19 Pandemic
por: Panwar, Rakshit, et al.
Publicado: (2020)

Future therapies for ARDS
por: Curley, Gerard F., et al.
Publicado: (2014)

Inhibition of pulmonary nuclear factor kappa-B decreases the severity of acute Escherichia coli pneumonia but worsens prolonged pneumonia
por: Devaney, James, et al.
Publicado: (2013)

Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome
por: Wang, Yan-Yang, et al.
Publicado: (2013)

Mesenchymal Stem Cell: Does it Work in an Experimental Model with Acute Respiratory Distress Syndrome?
por: Yilmaz, Sema, et al.
Publicado: (2012)

The effect of acute respiratory distress syndrome on bone marrow-derived mesenchymal stem cells
por: Antebi, Ben, et al.
Publicado: (2018)

Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

Mesenchymal stem cell‐derived extracellular vesicles for the treatment of acute respiratory distress syndrome
por: Abraham, Aswin, et al.
Publicado: (2019)

Personalized mechanical ventilation in acute respiratory distress syndrome
por: Pelosi, Paolo, et al.
Publicado: (2021)

Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome
por: Lin, Feng, et al.
Publicado: (2020)

Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome
por: Liu, Chang, et al.
Publicado: (2022)

Liponucleotides: Promises and Unknowns as Novel Therapeutics for Acute Respiratory Distress Syndrome
por: Hung, Chi F., et al.
Publicado: (2021)

Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome
por: Tovar, Isabel, et al.
Publicado: (2020)

Mesenchymal stem cell use in acute respiratory distress syndrome: a potential therapeutic application
por: Freitag, Julien, et al.
Publicado: (2020)

Therapeutic Benefits of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome: Potential Mechanisms and Challenges
por: Cao, Chao, et al.
Publicado: (2022)

Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives
por: Fernández-Francos, Silvia, et al.
Publicado: (2021)

Mesenchymal stromal cell therapy for acute respiratory distress syndrome due to coronavirus disease 2019
por: Whittaker Brown, Stacey-Ann, et al.
Publicado: (2022)

Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trial
por: Gorman, Ellen, et al.
Publicado: (2021)

Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19
por: Iglesias, Martin, et al.
Publicado: (2021)

Immunocompromised patients with acute respiratory distress syndrome: secondary analysis of the LUNG SAFE database
por: Cortegiani, Andrea, et al.
Publicado: (2018)

Epidemiology and patterns of tracheostomy practice in patients with acute respiratory distress syndrome in ICUs across 50 countries
por: Abe, Toshikazu, et al.
Publicado: (2018)

Antiplatelet Therapy for Acute Respiratory Distress Syndrome
por: Chen, Chuan-Mu, et al.
Publicado: (2020)

Fluid Therapy and Acute Respiratory Distress Syndrome
por: Lee, Jisoo, et al.
Publicado: (2021)

Gene Therapy for Acute Respiratory Distress Syndrome
por: Liu, Jing, et al.
Publicado: (2022)

Stem Cell‐based therapies for COVID‐19‐related acute respiratory distress syndrome
por: Ngai, Hoi Wa, et al.
Publicado: (2022)

Phenotypes and personalized medicine in the acute respiratory distress syndrome
por: Matthay, Michael A., et al.
Publicado: (2020)

A prospective investigation of interleukin-8 levels in pediatric acute respiratory failure and acute respiratory distress syndrome
por: Flori, Heidi, et al.
Publicado: (2019)

Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Supported with Extracorporeal Membrane Oxygenation. Lost in Translational Research?
por: Del Sorbo, Lorenzo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gh6dh29dgg4d6unm6jlt1t6qo9